Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.

Published in:

Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474

By:

• Bendell, Johanna;
• Sharma, Sunil;
• Patel, Manish R.;
• Windsor, Kevin S.;
• Wainberg, Zev A.;
• Gordon, Michael;
• Chaves, Jorge;
• Berlin, Jordan;
• Brachmann, Carrie Baker;
• Zavodovskaya, Marianna;
• Liu, JieJane;
• Thai, Dung;
• Bhargava, Pankaj;
• Shah, Manish A.;
• Khan, Saad A.;
• Starodub, Alexander

Publication type:

Article